[Moxonidine. A new centrally active antihypertensive drug].
Schrader
J
J
Abteilung Nephrologie/Rheumatologie, Medizinische Universitätsklinik Göttingen.
Molderings
G J
GJ
Dominiak
P
P
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007093:Imidazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014655:Vascular Resistance / Q000187:drug effects
D000959:Antihypertensive Agents; D007093:Imidazoles; C043482:moxonidine
Moxonidin. Ein neues zentral wirksames Antihypertensivum.